Profiling urinary metabolites of naproxen by liquid chromatography-electrospray mass spectrometry

被引:29
作者
Aresta, Antonella [1 ]
Carbonara, Teresa [1 ]
Palmisano, Francesco [1 ]
Zambonin, Carlo G. [1 ]
机构
[1] Univ Bari, Dipartimento Chim, Ctr Interdipartimentale Ric SMART, I-70126 Bari, Italy
关键词
naproxen; glucuronides characterization; metabolism; urine;
D O I
10.1016/j.jpba.2006.02.041
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Glucuronidation, an important metabolic process for the biotransformation of drugs into easily eliminable water-soluble detoxification products, can also lead to biologically active or toxic glucuronide conjugates. The present work describes a liquid chromatography-electrospray mass spectrometry (LC-ESI-MS) approach for the characterization of naproxen and O-6-desmethylnaproxen glucuronides. The method is fast and efficient and permitted to individuate alpha and O isomers of both naproxen and 0-6-desmethylnaproxen glucuronides. The procedure could be potentially extended to the characterization of other drug metabolites. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1312 / 1316
页数:5
相关论文
共 22 条
[1]  
ANDERSEN JV, 1992, J CHROMATOGR-BIOMED, V577, P325
[2]   Determination of naproxen in human urine by solid-phase microextraction coupled to liquid chromatography [J].
Aresta, A ;
Palmisano, F ;
Zambonin, CG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) :643-647
[3]   Glucuronic acid conjugates [J].
Bedford, CT .
JOURNAL OF CHROMATOGRAPHY B, 1998, 717 (1-2) :313-326
[4]  
BOYNTON C S, 1988, Journal of Clinical Pharmacology, V28, P512
[5]  
Dutton GJ, 1980, GLUCURONIDATION DRUG
[6]  
EBNER T, 1993, DRUG METAB DISPOS, V21, P50
[7]  
Green MD, 1998, DRUG METAB DISPOS, V26, P507
[8]   Simultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extraction [J].
Hirai, T ;
Matsumoto, S ;
Kishi, I .
JOURNAL OF CHROMATOGRAPHY B, 1997, 692 (02) :375-388
[9]  
JIN CJ, 1993, J PHARMACOL EXP THER, V264, P475
[10]  
KIANG CH, 1989, DRUG METAB DISPOS, V17, P43